The next time you view promotional information about a prescription drug on your smartphone, don’t be surprised if the risk information is harder to find than the benefits.
A new study by Food and Drug Administration staffers found that risks are not as “equally prominent and accessible” on smartphones, suggesting that many drug makers are not complying with regulations about providing information with so-called “fair balance.” The study was published earlier this week in the Journal of Medical Internet Research.
About the Author Reprints
